Jacobs Levy Equity Management, Inc Ani Pharmaceuticals Inc Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$50.28 - $64.61 $1.42 Million - $1.83 Million	-28,311 Reduced 88.42%	3,706 $215,000
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $115,263 - $166,388	-3,091 Reduced 8.8%	32,017 $1.72 Million
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $1.32 Million - $1.61 Million	35,108 New	35,108 $1.39 Million

213

18.6M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.